25 top inference chip startups: ranked
VC
🎤💳Join us Wednesday at 7 a.m. PT for a check-in on the state of private credit. Experts from PitchBook and Morningstar DBRS will dive into how lenders are managing existing loan books, what’s changing in loan underwriting, how AI is disrupting private credit business models and more in our upcoming webinar. Register here
Plus: $200 million for war dogs, L Catterton says goodbye to boxed mac-and-cheese and more ⬇️
AI’s center of gravity is shifting. By 2030, an estimated 75% of AI compute demand will come from inference, the work of running models rather than training them. That shift is redirecting capital toward purpose-built chips designed to beat general-purpose GPUs on cost, energy use and memory bottlenecks.
VC-backed inference deals hit $5.2 billion in 2025, and 2026 is on pace to top it, with $4.2 billion raised through late August, according to our research.
But raising money is only half the story. Our list ranks the top VC-backed inference AI chip companies by capital efficiency: How much post-money valuation has each built for every dollar of venture capital raised?
Etched leads the field at 12.3x, turning $1.7 billion raised into a $21 billion valuation. Israel’s Element Labs follows at 8.5x, ahead of photonic-compute player Luminous Computing at 6.1x.
Further down, you’ll find names PitchBook analysts are watching closely, including d-Matrix, which performs calculations directly in memory, and Tensordyne, whose chip swaps power-hungry multiplications for simpler additions.
PitchBook offers advertising, sponsorship and custom research solutions backed by best-in-class financial data. Promote your brand through newsletters, custom research, research report sponsorships, and website advertising designed to engage the private capital ecosystem of VC investors, institutional investors, companies, and advisors. Whether you need a branding campaign, lead generation, or thought leadership, our advertising solutions connect you with decision makers who matter.
Patrick T. Fallon/Getty Images
Venture investors have never invested more in AI neocloud companies, according to PitchBook data. It’s still not enough, according to Nvidia CEO Jensen Huang.
Global VC investment in AI neoclouds—companies that sell remote access to GPUs for AI workloads—has reached $6.6 billion across 58 deals so far this year. That’s more money and deals than any prior year and 51% above last year’s total of $4.4 billion.
In an interview with CNBC, Huang said that “the demand for neoclouds is off the chart,” but that “the demand of the capital is much greater” than availability.
Much of the AI neocloud sector is being funded by VC mega-rounds and by borrowing to bankroll chips.
“Working capital could be debt,” said David Yakobovitch, general partner at DataPower Capital, an investor in Nscale and Together AI. “It doesn’t necessarily mean equity.”
Nvidia itself has been investing heavily in the AI neocloud space. It is among the investors in Nscale and Together AI. It also sells the GPUs that neoclouds are raising money to buy.
“Jensen has a lot of skin in the game,” Yakobovitch said.
- Airbnb is cracking down on checkout chores, restricting what hosts can ask of their guests versus a cleaner. Some hosts oppose the new rules, and a petition to reverse the policy has gathered over 4,000 signatures. [The New York Times]
- Solar retailers are taking over Lagos’ biggest electronics market. High fuel prices and affordable solar technology from China are accelerating Nigeria’s shift to solar energy. [Bloomberg]
- The new private credit playbook: dancing on the beach and group meditation sessions. Fund managers are hosting elaborate events akin to music festivals to pitch to wealth advisors. [The Wall Street Journal]
Biotech startup Pathos AI, which uses an AI platform in oncology drug development, secured a $237 million Series E led by Bristol Myers Squibb at a $3 billion valuation.
Warhound, a startup genetically engineering dogs for military use supported by Colossal Biosciences’ Ben Lamm and Anduril’s Palmer Luckey, emerged from stealth with $200 million from investors including Sequoia, 8VC and Corner Ventures at a $1.2 billion valuation.
Star Therapeutics, a biotech developing drugs for diseases with unmet needs, raised a $200 million round led by OrbiMed and Janus Henderson Investors.
Tel Aviv-based AI security operations startup Mave emerged from stealth with $34 million in funding, including a $28 million Series A led by Red Dot Capital Partners and a $6 million seed round led by Dell Technologies Capital and Emerge Ventures.
Maxinsights, the developer of a data infrastructure platform for physical AI, raised a $30 million seed round led by Peak XV Partners.
QuantrolOx, a developer of a measurement and automation platform for quantum technologies, secured a €12 million Series A led by IW Capital.
Veritas Capital is considering a sale of Chromalloy, which provides aftermarket services to the aviation industry and could be valued at over $10 billion in a deal, Bloomberg reported.
Boxed mac-and-cheese company Goodles, which is backed by L Catterton, was acquired by Barilla. Barilla paid $750 million, Bloomberg reported.
Zetwerk, a manufacturing business backed by Peak XV Partners and Accel India, raised $518 million in its IPO and was valued at $2.7 billion after its market debut Friday.
Biotech Lycia Therapeutics, which develops treatments for allergies and autoimmune diseases and is backed by Versant Ventures, raised $317.5 million in its IPO.
Rivian acquired UK-based world model startup Third Dimension, which is backed by Abstract Ventures.
The Government of Canada announced the Venture and Growth Capital Catalyst Initiative, in which it will provide C$1 billion ($714 million) in total funding through Funds-of-Funds, Life Sciences and Emerging Manager streams toward private investments.
Partners Group closed its second rated feeder vehicle of 2026 for its private credit evergreen strategy, raising $510 million from US insurers and bringing its total raised through rated feeders to $875 million this year.
New evergreen fund launches reached a record high in 2025, led by credit strategies, though 2026 activity has slowed considerably.
Read more: Q3 2026 US Market Insights
